Xeris Pharmaceuticals (United States)

Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes

Michael R. Rickels, Stephanie N. DuBose, Elena Toschi et al. · Diabetes Care · 2018 · 75 citations · Full text

Development of a Highly Stable, Nonaqueous Glucagon Formulation for Delivery via Infusion Pump Systems

Brett Newswanger, Steve Ammons, Neelima V. Phadnis et al. · Journal of Diabetes Science and Technology · 2014 · 49 citations · Full text

Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)

Rosario Pivonello, Sabina Zacharieva, Miklós Tóth et al. · Pituitary · 2022 · 45 citations · Full text

Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes

Morey W. Haymond, Stephanie N. DuBose, Michael R. Rickels et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 42 citations · Full text

A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System for Postbariatric Hypoglycemia

Christopher M. Mulla, Stamatina Zavitsanou, Alejandro José Laguna Sanz et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 41 citations · Full text